Neurocrine Biosciences (NBIX) had the highest return in January 2015 by a large-cap US stock, returning 49%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | January 2015 | 49% |
AngloGold Ashanti (AU) | January 2015 | 45.13% |
Agnico Eagle Mines (AEM) | January 2015 | 38.42% |
Newmont Goldcorp (NEM) | January 2015 | 34.85% |
Gold Fields Ltd ADR (GFI) | January 2015 | 33.18% |
Pan American Silver (PAAS) | January 2015 | 28.84% |
Netflix (NFLX) | January 2015 | 28.41% |
Exelixis (EXEL) | January 2015 | 27.21% |
Coeur Mining (CDE) | January 2015 | 25.5% |
Coherent (COHR) | January 2015 | 24.93% |
Kinross Gold (KGC) | January 2015 | 22.82% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | January 2015 | 20.98% |
Franco-Nevada (FNV) | January 2015 | 19.45% |
Lululemon Athletica (LULU) | January 2015 | 18.26% |
Royal Gold (RGLD) | January 2015 | 17.74% |
Electronic Arts (EA) | January 2015 | 16.25% |
Wheaton Precious Metals (WPM) | January 2015 | 14.91% |
Diamondback Energy (FANG) | January 2015 | 14.89% |
Encompass Health (EHC) | January 2015 | 14.46% |
Stellantis (STLA) | January 2015 | 13.98% |
Sony (SONY) | January 2015 | 13.77% |
Tower Semiconductor (TSEM) | January 2015 | 13.55% |
Biogen (BIIB) | January 2015 | 13.51% |
Amazon (AMZN) | January 2015 | 13.42% |
MSCI (MSCI) | January 2015 | 12.85% |
Large-cap stocks are treated as having a market cap of $10B+.